6.
Sawant R, Vaze O, Wang T, DSouza G, Rockwell K, Gada K
. Palmitoyl ascorbate liposomes and free ascorbic acid: comparison of anticancer therapeutic effects upon parenteral administration. Pharm Res. 2011; 29(2):375-83.
DOI: 10.1007/s11095-011-0557-8.
View
7.
Delalande A, Kotopoulis S, Postema M, Midoux P, Pichon C
. Sonoporation: mechanistic insights and ongoing challenges for gene transfer. Gene. 2013; 525(2):191-9.
DOI: 10.1016/j.gene.2013.03.095.
View
8.
Wagai T
. Studies on the foundation and development of diagnostic ultrasound. Proc Jpn Acad Ser B Phys Biol Sci. 2013; 83(8):256-65.
PMC: 3859294.
DOI: 10.2183/pjab/83.256.
View
9.
Kato S, Asada R, Kageyama K, Saitoh Y, Miwa N
. Anticancer effects of 6-o-palmitoyl-ascorbate combined with a capacitive-resistive electric transfer hyperthermic apparatus as compared with ascorbate in relation to ascorbyl radical generation. Cytotechnology. 2011; 63(4):425-35.
PMC: 3140843.
DOI: 10.1007/s10616-011-9363-8.
View
10.
Kooiman K, Vos H, Versluis M, de Jong N
. Acoustic behavior of microbubbles and implications for drug delivery. Adv Drug Deliv Rev. 2014; 72:28-48.
DOI: 10.1016/j.addr.2014.03.003.
View
11.
Neumann J, Zeindl-Eberhart E, Kirchner T, Jung A
. Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer. Pathol Res Pract. 2009; 205(12):858-62.
DOI: 10.1016/j.prp.2009.07.010.
View
12.
Tejpar S, Bertagnolli M, Bosman F, Lenz H, Garraway L, Waldman F
. Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery. Oncologist. 2010; 15(4):390-404.
PMC: 3227961.
DOI: 10.1634/theoncologist.2009-0233.
View
13.
Ahmed D, Eide P, Eilertsen I, Danielsen S, Eknaes M, Hektoen M
. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. 2013; 2:e71.
PMC: 3816225.
DOI: 10.1038/oncsis.2013.35.
View
14.
Kurbacher C, Wagner U, Kolster B, Andreotti P, Krebs D, Bruckner H
. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett. 1996; 103(2):183-9.
DOI: 10.1016/0304-3835(96)04212-7.
View
15.
Chen Q, Espey M, Krishna M, Mitchell J, Corpe C, Buettner G
. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005; 102(38):13604-9.
PMC: 1224653.
DOI: 10.1073/pnas.0506390102.
View
16.
Batchelor D, Armistead F, Ingram N, Peyman S, McLaughlan J, Coletta P
. The Influence of Nanobubble Size and Stability on Ultrasound Enhanced Drug Delivery. Langmuir. 2022; 38(45):13943-13954.
PMC: 9671049.
DOI: 10.1021/acs.langmuir.2c02303.
View
17.
Podenphant M, Ashley N, Koprowska K, Mir K, Zalkovskij M, Bilenberg B
. Separation of cancer cells from white blood cells by pinched flow fractionation. Lab Chip. 2015; 15(24):4598-606.
DOI: 10.1039/c5lc01014d.
View
18.
Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D
. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2003; 22(2):229-37.
DOI: 10.1200/JCO.2004.05.113.
View
19.
Wu J, Nyborg W
. Ultrasound, cavitation bubbles and their interaction with cells. Adv Drug Deliv Rev. 2008; 60(10):1103-16.
DOI: 10.1016/j.addr.2008.03.009.
View
20.
Chiang C, Song E, Yang V, Chao C
. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells. Biochem J. 1994; 301 ( Pt 3):759-64.
PMC: 1137052.
DOI: 10.1042/bj3010759.
View